Funding for this research was provided by:
A. Alfred Taubman Medical Research Institute
Research to Prevent Blindness (n/a)
Received: 16 October 2018
Accepted: 28 April 2019
First Online: 9 May 2019
Ethics approval and consent to participate
: Study was IRB-exempt by the University of Michigan Institutional Review Board (application filed).
: Not applicable.
: T.W.G. is a consultant for Novo Nordisk and receives research funding from Zebra Biologics.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.